GoodRx Holdings, Inc. (GDRX) Nonoperating Income (Expense) USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
GoodRx Holdings, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2019 to 2024.
  • GoodRx Holdings, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was -$7.09 M, a 8.03% increase year-over-year.
  • GoodRx Holdings, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was -$27.9 M, a 4.05% decline year-over-year.
  • GoodRx Holdings, Inc. annual Nonoperating Income (Expense) for 2023 was -$28.6 M, a 14.4% decline from 2022.
  • GoodRx Holdings, Inc. annual Nonoperating Income (Expense) for 2022 was -$25 M, a 5.88% decline from 2021.
  • GoodRx Holdings, Inc. annual Nonoperating Income (Expense) for 2021 was -$23.6 M, a 15% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$27.9 M -$7.09 M +$619 K +8.03% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$28.6 M -$6.35 M +$135 K +2.08% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$28.7 M -$8.27 M -$1.71 M -26.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$27 M -$6.24 M -$128 K -2.09% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 -$26.9 M -$7.71 M -$1.89 M -32.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$25 M -$6.48 M -$596 K -10.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$24.4 M -$6.56 M -$643 K -10.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$23.7 M -$6.11 M -$219 K -3.72% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$23.5 M -$5.82 M +$72 K +1.22% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$23.6 M -$5.89 M +$308 K +4.97% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$23.9 M -$5.92 M +$326 K +5.22% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$24.2 M -$5.89 M +$845 K +12.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$25.1 M -$5.89 M +$2.67 M +31.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$27.7 M -$6.19 M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$6.24 M +$6.26 M +50.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$6.74 M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$8.56 M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q3 2019 -$12.5 M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.